Codexis (CDXS) to Release Earnings on Thursday

Codexis (NASDAQ:CDXS) is projected to announce its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $27.41 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Codexis Stock Performance

Shares of CDXS opened at $4.11 on Tuesday. The stock has a 50 day moving average of $4.68 and a 200 day moving average of $3.94. The company has a current ratio of 3.21, a quick ratio of 3.15 and a debt-to-equity ratio of 0.39. Codexis has a 12 month low of $2.56 and a 12 month high of $6.08. The company has a market capitalization of $334.47 million, a price-to-earnings ratio of -4.72 and a beta of 2.12.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CDXS shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $11.00 target price on shares of Codexis in a research note on Friday, November 22nd. Benchmark restated a “hold” rating on shares of Codexis in a report on Monday, November 4th.

About Codexis

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.